Home › Funds › Affinity Asset Advisors, LLC › COGT

Affinity Asset Advisors, LLC position in COGT

COGENT BIOSCIENCES INC · Health Care

Affinity Asset Advisors, LLC reported holding 11,000,000 shares of COGT (COGENT BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$12.1M, representing 0.56% of its reported portfolio and ranking #42 among its reported holdings. Affinity Asset Advisors, LLC has disclosed COGT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)11.00M sh
Reported value held$12.05M
Portfolio Weight0.56%
First reportedQ4 2025
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Affinity Asset Advisors, LLC's COGT position evolved

Affinity Asset Advisors, LLC first disclosed a stake in COGT in Q4 2025 at 1,000,000 shares (US$1.2M). The position peaked in Q2 2026 at 11,000,000 shares, worth US$13.7M. Across 4 filings, Affinity Asset Advisors, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 11,000,000 shares valued at US$12.1M. Notable position changes include a 600% increase in Q1 2026 (shares were roughly flat over the following quarter), a 57% increase in Q2 2026 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.00M $1.18M New
Q1 2026 7.00M $8.59M Add
Q2 2026 11.00M $13.65M Add
Q3 2026 11.00M $12.05M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COGT and 13F data

COGT (COGENT BIOSCIENCES INC) is a Health Care company. 54 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), TCG Crossover Management, LLC (US$187.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COGT

All COGT fund holders →

FAQ

How long has Affinity Asset Advisors, LLC held COGT?

Affinity Asset Advisors, LLC has disclosed COGT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Affinity Asset Advisors, LLC's current position in COGT?

As of Q3 2026, Affinity Asset Advisors, LLC holds 11.00M shares of COGT (COGENT BIOSCIENCES INC), valued at $12.05M, representing 0.56% of its reported portfolio and ranking #42.

Has Affinity Asset Advisors, LLC been buying or selling COGT?

In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC held unchanged its position in COGT. The position peaked in Q2 2026 at 11.00M shares.

Which other funds hold COGT?

Other major institutional holders of COGT include Fairmount Funds Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P., TCG Crossover Management, LLC, among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.